Key result
Cannabis use is potentially associated with an increased risk of myocardial infarction, highlighting the need for clinicians to assess recent use in young healthy patients presenting with chest pain.
Why the study?
Does cannabis use increase the risk of myocardial infarction in young healthy patients?
Does cannabis use increase the risk of myocardial infarction in young healthy patients?
Answers are grounded in this paper and cite their sources.
Clinicians should be aware of the potential increased risk of myocardial infarction in young healthy patients presenting with chest pain and a recent history of cannabis use.
Pre-clinical research and case reports have linked cannabis use to myocardial infarction (MI) since the 1970s. The association with MI may be specific to certain types and patterns of cannabis use as well as certain consumer characteristics; however, due to limited data availability, meta-analyses examining the association between cannabis use and MI typically report only broad binary categorisations of use vs. no use. Robust prospective studies that capture the complexities of consumption patterns are required to inform causal inferences. In the meantime, clinicians should be aware of the potential increased risk of myocardial infarction in young healthy patients presenting with chest pain and a recent history of cannabis use. Accurate assessment and documentation of recent cannabis use is also essential to improve future research and identify and monitor interactions with cardiovascular medications.
No takes yet. Share an insight, caveat, or question.
Padmanathan et al. (2025) conducted an editorial in Myocardial infarction. Cannabis use vs. No use was evaluated on Myocardial infarction. Cannabis use is potentially associated with an increased risk of myocardial infarction, highlighting the need for clinicians to assess recent use in young healthy patients presenting with chest pain.
Synapse has enriched 10 related papers. Consider them for comparative context: